AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license a... AEterna Zentaris Inc is a biopharmaceutical company commercializing & developing therapeutics & diagnostic tests. The company's product, Macrilen (macimorelin), is the oral test indicated for the diagnosis of adult growth hormone deficiency (GHD). Macrilen is marketed in the U.S. through a license agreement with Novo Nordisk & the company receives royalties on sales. Aeterna owns all rights to macimorelin outside of the U.S. & Canada. It is leveraging the clinical success & safety profile of macimorelin to develop it for the diagnosis of child-onset GHD. The company's geographical segments include Switzerland, Ireland, Denmark, and others, of which nearly all of its revenue comes from Switzerland. 더 보기
- Top-line data with unexpected results requiring further clarification, did not meet primary endpoint as per protocol - Potent growth hormone release following macimorelin stimulation - Safety of...
Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended the quarter with US$27.8...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 5.07614213198 | 3.94 | 4.31 | 3.925 | 5331 | 4.09646121 | CS |
4 | -1.51 | -26.7256637168 | 5.65 | 6.4 | 3.49 | 13508 | 4.10216175 | CS |
12 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11146 | 4.26591754 | CS |
26 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11146 | 4.26591754 | CS |
52 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11146 | 4.26591754 | CS |
156 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11146 | 4.26591754 | CS |
260 | -2.075 | -33.3869670153 | 6.215 | 6.7738 | 3.49 | 11146 | 4.26591754 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관